论文信息 - Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol - 字舞流文

Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol

P. Hillemanns | L. Sui | Youzhong Zhang | J. Lang | C. Dannecker | Y. Zhang | F. Chen | Z. Novák | L. Sui | Z. You | L. Han | J. Lang | Z. You | Z. Novák | Fei Chen | Ling Han | Ctirad Mokráš